Skip to content

Clinical trials

Phase 2 Retinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Phase: Phase 2 Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20073
20091
20102
20113
20122
20131
20152
20192
20205
20214
20221
20234
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated7
Unknown status2
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gyroscope Therapeutics Limited3
Laboratoires Thea3
Neurotech Pharmaceuticals3
Gemini Therapeutics, Inc.2
National Eye Institute (NEI)2
Oraya Therapeutics, Inc.2
Unity Biotechnology, Inc.2
Adverum Biotechnologies, Inc.1
Alcon Research1
Alkahest, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases37
Eye Diseases17
Retinal Degeneration12
Macular Degeneration10
Retinitis Pigmentosa8
Macular Edema7
Diabetes Mellitus6
Diabetic Retinopathy6
Geographic Atrophy6
Edema4

Trials

Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.